A pproximately 100 million cholesterol tests are performed annually in US ambulatory clinics alone. 1 Controlling cholesterol is one of the American Heart Association's Life's Simple 7 and a central aspect of atherosclerotic cardiovascular disease prevention in the United States and abroad. 2 Guidelines recommend using the standard lipid profile in several ways. [3] [4] [5] [6] [7] On initial patient evaluation, estimating a 10-year atherosclerotic cardiovascular disease risk score using the 2013 US pooled cohort equations, the Framingham risk score or European systemic coronary risk estimation score is one of the components for eligibility for primary prevention statin therapy. [3] [4] [5] [6] [7] These risk scores include total cholesterol (TC) and high-density lipoprotein cholesterol (HDL-C) as individual variables. Baseline low-density lipoprotein cholesterol (LDL-C) is also used to define treatment eligibility, and after intervention on-treatment LDL-C levels are compared with baseline and monitored over time, as are non-HDL-C and apolipoprotein B (apoB) levels in some guidelines. [4] [5] [6] [7] Current guidelines do not recommend using the TC/ HDL-C ratio. It remains uncertain what information the ratio may add given that TC and HDL-C are already used in risk estimation, in estimating LDL-C by the Friedewald formula [LDL-C = TC -HDL-C -(triglycerides/5)], 8 and in calculating non-HDL-C. Moreover, Mendelian randomization and HDL-C raising trials argue against a causal role of HDL-C in atherosclerotic cardiovascular disease. [9] [10] [11] However, to some extent, it has been suggested that TC/HDL-C may be a marker of atherogenic particle burden. 12 Previous studies have shown tracking of TC/HDL-C with LDL particle concentration (LDL-P) and its association with risk for cardiovascular events. [13] [14] [15] [16] Before considering additional tests (eg, LDL-P, apoB), it may be desirable to extract as much information as possible from the standard lipid profile. We have previously shown significant patient-level percentile discordance between LDL-C and non-HDL-C suggesting additional information carried by non-HDL-C. 17 Likewise, TC/HDL-C may offer potential additional clinical information to LDL-C and non-HDL-C if it is significantly discordant with them within individuals. Therefore, the primary aim of this study was to examine the extent of patient-level percentile TC/HDL-C discordance.
Methods

Study Population and Lipid Testing
We examined consecutive lipid profiles from 1 310 432 US adults ≥18 years of age with triglycerides (TGs) <400 mg/dL from the Very Large Database of Lipids (VLDL) . 18 This study is part B of the VLDL-2 study that specifically aims to assess discordance between lipid parameters. In VLDL-2A, 17 we examined discordance between LDL-C and non-HDL-C and in this study (VLDL-2B) we examine discordance between TC/HDL-C versus LDL-C and non-HDL-C. Lipid profiles were measured using direct ultracentrifugation by the Vertical Auto Profile test (Atherotech Diagnostics Laboratory, Birmingham, AL). 18, 19 The accuracy and precision of Vertical Auto Profile lipid parameters have been validated, as previously described. 18, 19 Lipid distributions in the VLDL population were nearly superimposable with lipid distributions from the National Health and Nutrition Examination Survey (NHANES; Figure I in the online-only Data Supplement). 18 LDL-C in the main analyses was estimated by the Friedewald formula given its longstanding use in clinical practice worldwide. 8 To address bias associated with the Friedewald LDL-C estimation method, we performed supplemental analyses using LDL-C estimated by our recently described novel method, 20 and Vertical Auto Profile-measured direct LDL-C, as well.
The Johns Hopkins Institutional Review Board declared our study exempt, and further information regarding data extraction and management has been previously described.
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Statistical Analysis
We assigned population percentiles to TC/HDL-C, LDL-C, and non-HDL-C, and also determined the TC/HDL-C percentiles corresponding to LDL-C and non-HDL-C cut points still used in some current worldwide guidelines such as the Canadian Cardiovascular Society, European Society of Cardiology and European Atherosclerosis Society, National Lipid Association, and International Society of Atherosclerosis cholesterol guidelines (Table I in the online-only  Data Supplement) . [4] [5] [6] [7] We used pseudocolor-encoded density scatter plots to visually assess discordance between TC/HDL-C, LDL-C, and non-HDL-C percentiles in the whole population and across TG categories of <100, 100 to 149, 150 to 199, and 200 to 399 mg/dL. To quantify the magnitude of discordance, we calculated the difference between TC/ HDL-C percentile, LDL-C percentile, and non-HDL-C percentile for every patient as follows: (TC/HDL-C percentile minus LDL-C percentile) and (TC/HDL-C percentile minus non-HDL-C percentile). We calculated the median with first to third quartiles (Q1-Q3) of discordance. In supplemental analyses, the same calculations were performed to study discordance of TC/HDL-C with direct LDL-C and LDL-C estimated by the novel method. 20 After considering the heterogeneous definitions of discordance in the literature, 17, [21] [22] [23] [24] [25] we quantified discordance at the 4 arbitrary thresholds of ≥5, ≥10, ≥25, and ≥50 percentile units discordance and chose the 10th and 25th percentile unit cut points for further analyses. For each percentile unit (x) cut point, the population was divided into patients with TC/HDL-C percentile > LDL-C percentile by ≥(x) percentile units, patients with TC/HDL-C percentile < LDL-C percentile by ≤(x) percentile units and patients with concordant TC/HDL-C and LDL-C percentiles within ± (x) percentile units. The same method was used in all other discordance analyses.
In patients with Friedewald LDL-C or non-HDL-C <15th population percentile (Friedewald LDL-C <70 mg/dL, non-HDL-C <93 mg/ dL), we examined the proportion of discordant patients above the percentile-equivalent TC/HDL-C of 2.6 across TG categories. Similarly, in patients with direct and novel method LDL-C <12th percentile (70 mg/dL), we examined the proportion of discordant patients above the percentile-equivalent TC/HDL-C of 2.5.
Next, we compared age, sex, and multiple lipid parameters derived from the standard lipid profile between the 2 discordant (TC/HDL-C > LDL-C or non-HDL-C and TC/HDL-C < LDL-C or non-HDL-C) and concordant patient populations. This analysis was performed using a discordance definition of ≥10 and ≥25 percentile units. Subsequently, linear regression models of multiple variables were used to determine the strength of association (R 2 ) with discordance. TC/HDL-C -LDL-C percentile discordance and TC/HDL-C -non-HDL-C percentile discordance followed a normal distribution and were used as continuous outcomes. The natural log of TG [ln(TG)] was used in the model given that TG levels followed a log normal distribution. We initially forced in age, sex, and ln(TG) because TG is not involved in calculating TC/HDL-C or non-HDL-C. We then sequentially added TC followed by HDL-C. Subsequently, we used various combinations of lipid parameters including HDL-C subfractions (HDL 2 -C, HDL 3 -C) and logarithmic LDL density ratio. 26 In addition, we standardized continuous predictor variables (per 1 standard deviation) to make them more comparable.
Statistical analyses and logarithmically scaled pseudocolorencoded density plots were generated using R Version 2.15.1 (Vienna, Austria), Stata Version 11.0 (College Station, TX), and Microsoft Excel 2010 (Redmond, WA).
Results
TC/HDL-C Discordance With LDL-C and Non-HDL-C discordance shifted toward TC/HDL-C > LDL-C or non-HDL-C percentiles ( Figures 1B and 2B) .
In Figure 3 , we observed that 67% and 34% of patients had ≥10 percentile units and ≥25 percentile units discordance between TC/HDL-C and LDL-C, respectively. On a smaller scale, 60% and 25% of patients had ≥10 percentile units and ≥25 percentile units discordance between TC/HDL-C and non-HDL-C, respectively. In contrast to TC/HDL-C discordance, non-HDL-C versus LDL-C percentile discordance was relatively small with only 3% having ≥25 percentile units discordance.
Discordance of ≥10 and ≥25 percentile units between TC/ HDL-C and LDL-C estimated by the novel method was also significant, occurring in 64% and 30% of patients, respectively (online-only Data Supplement Table II ). Discordance of ≥10 and ≥25 percentile units between TC/HDL-C and direct LDL-C occurred in 65% and 31% of patients, respectively (online-only Data Supplement Table II) .
Examining TC/HDL-C -LDL-C percentile discordance, the median (Q1-Q3) discordance in percentile units was -13.3 (-29.8 to 0.1), 0.1 (-14.2 to 14.9), 10.6 (-2.6 to 27.4), and 25.7 (7.2-46.1) in patients with TG levels <100, 100 to 149, 150 to 199, and 200 to 399 mg/dL, respectively (Table 1) . To a smaller extent, TC/HDL-C -non-HDL-C percentile discordance was -5.1 (-20.3 to 6.2), 1.0 (-12.7 to 15.2), 4.9 (-6.5 to 19.4), and 7.2 (-1.5 to 22.0), respectively ( Table 1) .
The proportion of patients with TC/HDL-C > LDL-C by ≥25 percentile units increased gradually from 3% in the TG <100 mg/dL group to as high as 51% in the TG 200 to 399 mg/dL group (Table 1) . This was much larger than TC/ HDL-C > non-HDL-C discordance where the proportion of patients increased from 6% to 21% across the respective TG groups (Table 1) . On the other hand, the proportion of patients with TC/HDL-C < LDL-C by ≥25 percentile units decreased gradually with increasing TG levels and was much larger than TC/HDL-C < non-HDL-C discordance (Table 1) . TC/ HDL-C discordance with direct LDL-C and LDL-C estimated by the novel method was less dramatic at higher TG levels in comparison with Friedewald LDL-C (online-only Data Supplement Table II) .
We also assessed TC/HDL-C discordance with LDL-C and non-HDL-C at the LDL-C goal <70 mg/dL recommended by multiple guidelines. [4] [5] [6] [7] In our population, LDL-C of 70 mg/dL was the percentile-equivalent of non-HDL-C of 93 mg/dL and TC/HDL-C of 2.6 (15th percentile; Table I in the online-only Data Supplement). In patients with <15th percentile levels of Friedewald LDL-C or non-HDL-C, a respective 58% and 46% were at or above the percentile-equivalent TC/HDL-C http://circ.ahajournals.org/ Downloaded from of 2.6. When studied across TG categories, the percentage of patients with LDL-C <15th percentile and TC/HDL-C ≥15th percentile, increased from 29% at TG levels <100 mg/dL to 96% at TG levels 200 to 399 mg/dL ( Figure 4A ). A similar analysis showed that the percentage of discordant patients with non-HDL-C <15th percentile and TC/HDL-C ≥15th percentile increased from 33% at TG levels <100 mg/dL to 87% at TG levels 200 to 399 mg/dL ( Figure 4B ). Similar analyses revealed that 57% of patients with direct LDL-C <12th percentile (70 mg/dL) and 56% with novel method LDL-C <12th percentile (70 mg/dL) were above the percentile-equivalent TC/HDL-C ratio of 2.5 ( Figure II in the online-only Data Supplement).
Characteristics of Discordant Versus Concordant Patient Populations
Using discordance definitions of ≥10 and ≥25 percentile units, we compared 3 groups of patients as follows: TC/HDL-C > LDL-C percentile, concordant percentiles, and TC/HDL-C < LDL-C percentile (Table 2) . Age was similar between the 3 groups of patients at both levels of discordance (≥10 percentile units and ≥25 percentile units discordance). Patients with TC/ HDL-C > LDL-C, in comparison with the concordant and TC/ HDL-C < LDL-C, were more commonly male (approximately two-thirds) with a more atherogenic lipid phenotype characterized by lower HDL-C and its subfractions, and higher TG, TG/HDL-C ratio, and LDL density (logarithmic LDL density ratio). 26 However, TC and LDL-C levels were lower in these patients. We observed similar results when comparing the 3 TC/HDL-C versus non-HDL-C groups (Table 3) .
Explaining Discordance
In a linear regression model using TC/HDL-C -LDL-C percentile discordance as a continuous outcome, age, sex, and ln(TG) (model A) explained 40% of discordance (R 2 0.4). Adding TC to the model increased R 2 to 0.74 (model B), and consecutively adding HDL-C increased R 2 to 0.88 (model C). For each 1 standard deviation increment in ln(TG), discordance increased by 20 and 12 percentile units in models B and C, respectively (Table 4 , TC/HDL-C -LDL-C Percentile Discordance). For TC/HDL-C -non-HDL-C percentile discordance, age, sex and ln(TG) explained 21% of discordance (R 2 0.21) which increased to 0.64 and 0.86 by adding TC then consecutively HDL-C in models B and C, respectively (Table 4 , TC/HDL-C -Non-HDL-C Percentile Discordance). For each 1 standard deviation increment in ln(TG), discordance increased by 10 and 2 percentile units in models B and C, respectively, a smaller change than TC/HDL-C versus LDL-C discordance. More regression models using HDL subfractions and logarithmic LDL density ratio are shown in Table III in the online-only Data Supplement. Models incorporating HDL 3 -C were better at explaining discordance than HDL 2 -C, whereas logarithmic LDL density ratio added minimally to the prediction of discordance. Three-dimensional plot of the extent of discordance between TC/HDL-C, LDL-C, and non-HDL-C percentiles across different percentile units thresholds. On the X axis, we present discordance between TC/HDL-C and LDL-C percentiles, TC/HDL-C and non-HDL-C percentiles, and LDL-C and non-HDL-C percentiles from left to right, respectively. On the Y axis, we represent the magnitude (%) of patient-level discordance at thresholds of ≥5, ≥10, ≥25, and ≥50 percentile units. LDL-C indicates low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein cholesterol; and TC/HDL-C, total cholesterol to HDL-C ratio. 
Discussion
Our cross-sectional study of 1.3 million patients shows the existence of significant patient-level TC/HDL-C discordance in relation to LDL-C and non-HDL-C. Patients with a disproportionately high TC/HDL-C do not differ in age, but tend to be male and have a more atherogenic lipid phenotype with lower HDL-C and higher TG, whereas patients with disproportionately low TC/HDL-C have a less atherogenic phenotype. Discordance is largely explained by age, sex, and levels of standard lipid parameters, predominantly the latter. Overall, the finding of significant TC/HDL-C discordance may suggest potential additional information in TC/HDL-C not available in LDL-C or non-HDL-C alone.
Perhaps the most striking and original finding in our big data analysis is the sizable discordance between TC/HDL-C and non-HDL-C. TC/HDL-C is calculated from the same 2 data points as non-HDL-C, with the only difference being the mathematical operation of division, rather than subtraction. Although one might intuit that there is no additional information to extract from dividing rather than subtracting TC and HDL-C, this question requires careful attention and empirical evidence.
We document considerable TC/HDL-C discordance with non-HDL-C. We found only 1 previous study examining patient-level TC/HDL-C and non-HDL-C discordance. In 692 severely hypercholesterolemic patients, TC/HDL-C was only modestly correlated with non-HDL-C (r=0.39), 27 in comparison with r=0.70 in our study. The difference in correlation may be due to the relatively small size and high cholesterol levels in the previous study population with mean non-HDL-C and TC/HDL-C of 192 mg/dL and 6.7, respectively, in comparison with our larger population with means of 136 mg/dL and 3.7, respectively. In the previous study, among low-risk patients with a non-HDL-C <190 mg/dL, only 8% had TC/HDL-C ≥6.0, but among high-risk patients with non-HDL-C <130 mg/dL, 58% had a TC/HDL-C ≥3.5 consistent with findings in our study.
Previous studies have shown that particle-based measures such as LDL-P or apoB are discordantly greater than LDL-C more frequently in patients with insulin resistance, lower HDL-C, lower LDL-C, higher TG, and those on statins. 22, 25, 28, 29 To our knowledge, our study is the first and largest to evaluate the characteristics of patients with TC/HDL-C discordance.
We found that those with disproportionately high TC/HDL-C were most commonly men and had a generally more atherogenic lipid phenotype characterized by lower HDL-C and its subfractions, higher TG, and higher LDL density. 21, 22, 26, 28 TG/ HDL-C, an important marker associated with insulin resistance and inversely associated with LDL particle size, 30 was also higher. Our findings suggest that the lipid phenotype of these patients is, in general, comparable to those with obesity, diabetes mellitus, and metabolic syndrome who have a prevalence of TG-rich remnant lipoproteins and cholesteroldepleted apoB particles. 22, 28 This phenotype may be associated with a higher risk of coronary events in comparison with patients with cholesterol-rich apoB particles. 31 Using linear All values reported other than n (%) are median (Q1-Q3). HDL-C indicates high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LLDR, logarithmic LDL-C density ratio; non-HDL-C, non-high-density lipoprotein cholesterol; Q1-Q3, first to third quartile; TC, total cholesterol; and TG, triglycerides. All values reported other than n (%) are median (Q1-Q3). HDL-C indicates high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LLDR, logarithmic LDL-C density ratio; non-HDL-C, non-high-density lipoprotein cholesterol; Q1-Q3, first to third quartile; TC, total cholesterol; and TG, triglycerides.
by guest on July 29, 2017 http://circ.ahajournals.org/ Downloaded from regression, we have also shown that >86% of the variance in discordance is fundamentally explained by age, sex, and the 3 directly measured standard lipid parameters, a finding that in the future may help clinicians focus attention on certain patient clusters, such as those with low TC and HDL-C, where significant discordance exists and risk may track more closely to TC/HDL-C.
By inversely integrating HDL-C, a higher TC/HDL-C ratio may reflect, to some extent, discordance between particle cholesterol content and concentration that tends to occur in patients with insulin resistance and low HDL-C levels. 28 This novel concept suggests that potential additional information contained in TC/HDL-C may not be due to the contentious conviction of an inverse relationship between HDL-C and CVD, 9 but instead, TC/HDL-C might provide a partial gateway to lipoprotein particle concentration and size information from the standard lipid profile. A recent analysis showed that TC/HDL-C ratio of <3 was the standard lipid profile measure that was most correlated with a LDL-P of <1000 nmol/L. 12 In another study, the significant difference in LDL size between patients with coronary artery disease and controls became nonsignificant after adjusting for TC/HDL-C. 32 Although more study is needed, this initial evidence indicates that TC/HDL-C may carry information related to particle concentration and size.
If viewed in this way, as a marker of atherogenic lipoprotein burden, TC/HDL-C may be more acceptable for clinical use with focus shifted away from the lack of proven HDL-C raising strategies. By such a view, lowering a discordantly elevated TC/HDL-C may be desirable to achieve a further lowering in atherogenic lipoproteins. Retention of apoB-containing lipoproteins is the fundamental event leading to subendothelial accumulation of cholesterol and atherosclerosis. 22, 28, 33 However, both non-HDL-C and LDL-C are inherently cholesterol-, not particle-, focused measures. When small, dense lipoproteins predominate, non-HDL-C and LDL-C may underestimate the burden of circulating atherogenic particles. Particle burden can be measured with an added test, or, for no additional cost, perhaps TC/HDL-C could be considered first.
At present, we can only comment on overall populationlevel risk signals for TC/HDL-C in comparison with non-HDL-C and LDL-C. The TC/HDL-C ratio has been strongly associated with cardiovascular risk. [14] [15] [16] [34] [35] [36] In the Women's Health Study, TC/HDL-C was better than LDL-C and as good as or better than non-HDL-C and apolipoprotein fractions in the prediction of future cardiovascular events. 15 In another Women's Health Study, the net reclassification index for adding either apoB or LDL-P to TC/HDL-C was only 2%. 16 Similar results were demonstrated in the Framingham population, 35 Physicians Health Study, 37 and in statin-treated patients. 34 In a meta-analysis of ≈900 000 patients with 55 000 vascular deaths, TC/HDL-C was suggested to provide 40% more risk information than non-HDL-C. 38 Rather than the question of the general population risk information in a given lipid parameter, the most clinically relevant question when considering additional parameters would seem to be: in those who have discordance, does discordance relate to greater atherosclerosis or greater risk of events? That is, related lipid parameters should be compared for risk signals when they disagree, not when they agree. This is a relatively new approach to epidemiological analysis. Two studies have examined discordance between particle-based measures such as LDL-P and apoB versus non-HDL-C in this way. 23, 39 In these studies, discordance was sizeable and cardiovascular outcomes, including events, coronary artery calcium, and carotid intimal medial thickness, tracked more closely with LDL-P and apoB. However, there are no conclusive outcome data to suggest that an advantage lies in the direction of the TC/HDL-C ratio in instances of discordance; thus, additional clinical studies using the patient-level discordance approach are warranted.
Study Limitations
Our study limitations have been described in detail. 18 Although we lack important clinical characteristics, such as statin use, our population represents a contemporary population of 1.3 million patients with parallel age, sex, and lipid distributions to the NHANES population ( Figure I in the online-only Data Supplement). As a cross-sectional study, we cannot determine whether TC/HDL-C discordance relates to risk for cardiovascular events, and if so, what magnitude of discordance is clinically significant. We note, however, that discordance between apoB and non-HDL-C of >5 percentiles was clinically significant, 23 whereas another study showed that >12 The results shown are: coefficient (standard error); T statistic. All covariates, except sex, were standardized by their standard deviations. All values are statistically significant (P<0.0001). HDL-C indicates high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein cholesterol; TC, total cholesterol; and TG, triglycerides.
*Natural log of triglycerides attributable to log normal distribution of triglycerides.
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Conclusions
Our contemporary, big data analysis demonstrates that a substantial proportion of patients have significant discordance of TC/HDL-C with LDL-C and non-HDL-C. Therefore, the fundamental criterion for potential additional informationthe existence of discordance -is met. TC/HDL-C, available at no extra cost, warrants continued investigation of its potential clinical importance through discordance analyses in studies with longitudinal follow-up for clinical events.
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